IHAM
EWTX icon

Integral Health Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Integral Health Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-300,000
Closed -$6.6M – 85
2025
Q1 		$6.6M Hold
300,000
– – 0.7% 44
2024
Q4 		$8.01M Sell
300,000
-200,000
-40% -$6.37M 0.68% 49
2024
Q3 		$13.3M Buy
+500,000
New +$9.95M 1.5% 20

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Integral Health Asset Management's EWTX Position: Q1 2026 in Review

Integral Health Asset Management increased its Edgewise Therapeutics (EWTX) stake by 6.7% in Q1 2026, buying an estimated $2.88M and bringing the position to 1,600,000 shares worth $50.4M. The position accounts for 2.41% of the portfolio, ranked #13.

Integral Health Asset Management first reported a position in EWTX in Q4 2024 and has held it in 6 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Integral Health Asset Management held 1,600,000 shares of Edgewise Therapeutics worth $50.4M as of Q1 2026.
  • Integral Health Asset Management bought 100,000 Edgewise Therapeutics shares in Q1 2026, an estimated $2.88M.
  • Edgewise Therapeutics made up 2.41% of Integral Health Asset Management's portfolio in Q1 2026, its #13 holding.
  • Integral Health Asset Management first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.